Skip to main content
. Author manuscript; available in PMC: 2013 Jan 15.
Published in final edited form as: Neurology. 2007 May 23;69(11):1113–1121. doi: 10.1212/01.wnl.0000267701.58488.69

Table 2.

Current symptoms among neuropathologic groups

Symptoms bvFTD-FTLD, n (%) bvFTD-AD, n (%) Significance (χ2) τ-Positive, n (%) τ-Negative, n (%) Significance (χ2)
Memory 65 (87.8) 21 (100) NS 20 (86.9) 45 (88.2) NS
Judgment and problem-solving 73 (98.6) 21 (100) NS 23 (100) 50 (98.0) NS
Language 66 (89.2) 18 (85.7) NS 19 (82.6) 47 (92.1) NS
Visuospatial 40 (54.1) 16 (76.2) NS 11 (47.8) 19 (37.3) NS
Attention/concentration 57 (77.0) 18 (85.7) NS 18 (78.2) 39 (76.4) NS
Apathy/withdrawal 54 (73.0) 15 (71.4) NS 17 (73.9) 37 (72.5) NS
Depression 32 (43.2) 12 (57.1) NS 10 (43.5) 22 (43.1) NS
Psychosis 11 (14.9) 6 (28.5) NS 4 (17.3) 7 (13.7) NS
Disinhibition 49 (66.2) 14 (66.7) NS 17 (73.9) 32 (62.7) NS
Irritability 27 (36.5) 13 (61.9) NS 8 (34.7) 19 (37.2) NS
Agitation 25 (33.8) 12 (57.1) NS 7 (30.4) 18 (35.3) NS
Personality change 58 (78.3) 11 (52.4) 4.33; p < 0.05 18 (78.2) 40 (78.4) NS
Gait disorder 39 (52.7) 7 (33.3) NS 9 (39.1) 30 (58.8) NS
Falls 24 (32.4) 7 (33.3) NS 6 (26.1) 18 (35.3) NS
Tremors 21 (28.4) 8 (38.1) NS 6 (26.1) 15 (29.4) NS
Slowness 37 (50) 8 (38.1) NS 10 (43.5) 27 (52.9) NS

Abbreviations: AD = Alzheimer disease; bvFTD = behavioral variant frontotemporal dementia; FTLD = frontotemporal lobar degeneration.